Immunotherapy for hepatocellular carcinoma in liver transplant patients (Literature review)

Immunotherapy for hepatocellular carcinoma in liver transplant patients (Literature review)

Hepatocellular carcinoma (HCC) is the third cause of cancer-related mortality worldwide, accounting for more than 800,000 deaths annually. Surgical removal of the neoplasm remains the most effective treatment option. Partial liver resection is an adequate solution for patients without cirrhosis or w...

Full description

Saved in:
Bibliographic Details
Main Authors: I. A. Dzhanyan, M. S. Novruzbekov, O. D. Olisov, D. I. Yudin, V. S. Rudakov, E. Yu. Antonova, I. V. Savchenko, I. V. Pogrebnyakov, V. V. Breder, M. Yu. Pitkevich
Format: Article
Language:Russian
Published: Private institution educational organization of higher education "Medical University "ReaViz" 2023-09-01
Series:Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье
Subjects:
hepatocellular carcinoma
tyrosine kinase inhibitors
immune checkpoint inhibitors
therapy for recurrent hepatocellular carcinoma
orthotopic liver transplantation
retreat index
regorafenib
nivolumab
Online Access:https://vestnik.reaviz.ru/jour/article/view/823
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://vestnik.reaviz.ru/jour/article/view/823

Similar Items